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Background, Objectives/Goal, Methods/Design, Results, Conclusions limited to 500 words

Background:
Patients with dedicator of cytokinesis 8 (DOCK8) deficiency are prone to severe, recurrent or chronic
mucocutaneous herpes simplex virus (HSV) infections that may develop antiviral resistance. We present the
case of a child with DOCK8 deficiency and chronic, resistant HSV-1 mucocutaneous infections to illustrate
the potential clinical utility of an investigational viral whole genome sequencing approach to detecting
active and latent HSV resistance mutations longitudinally.

Methods/Design:
We abstracted clinical and laboratory data in a 14 year old boy with DOCK8 deficiency with repeated viral
culture growth of HSV-1. HSV-1 DNA from seven positive viral culture specimens collected during 2015-

2018 were sequenced on an Illumina® MiSeq to >150X depth. Consensus genomes were called using an
established HSV genome pipeline, and reads were mapped to the HSV-1 strain reference genome
(NC_001806). Sequence variants were checked against an online database of UL23 (thymidine kinase) and
UL30 (DNA polymerase) variants associated with antiviral resistance.

Results:
The patient had low CD4+ T cells (initial 248 cells/mm3), eosinophilia, elevated IgE (initial 9660 kU/L),
severe eczematous dermatitis, chronic obstructive and interstitial lung disease, growth delay, and presented
with recurrent infections including Staphylococcus aureus, Candida albicans, JC virus, and HSV-1. He was
receiving prophylaxis with subcutaneous immunoglobulin G, trimethoprim-sulfamethoxazole, and acyclovir.
Family declined hematopoietic stem cell transplantation. Mucocutaneous HSV-1 infections extensively
involved his face, trunk, and extremities with more severe infections involving his cornea, lips, perineum,
scalp, and periorbital regions. Scalp and periorbital lesions were proliferative and edematous papules and
plaques consistent with HSV vegetans (Figures 1-2) and confirmed by scalp biopsy. Although early HSV-1
infections responded to oral or IV acyclovir, clinical response decreased over time, requiring advancement
of therapies to high-dose acyclovir IV, foscarnet IV, cidofovir IV, topical cidofovir cream, and/or interferonalpha with variable clinical response.
Phenotypic testing detected acyclovir resistance in HSV isolated from four samples while the patient was on
acyclovir and no resistance in a sample while not on acyclovir. Phenotypic foscarnet resistance was detected
in one sample without prior patient exposure to foscarnet. Viral whole genome sequencing detected the
UL23 variant R176Q (associated with acyclovir resistance) on all specimens, whether on acyclovir or not,
and the UL30 variant T821M (associated with acyclovir and cidofovir resistance) only when on cidofovir.
When phenotypic testing and genome sequencing were discordant, clinical response appeared to be more
consistent with genome sequencing results.

Conclusions:
This patient with DOCK8 deficiency illustrates the potential severity of chronic, resistant mucocutaneous
HSV-1 infection. Viral genome sequencing for antiviral resistance mutations may provide additional
information about the presence of clinically significant variants, which may result from detecting smaller or
latent HSV-1 sub-populations.

Figure 1. HSV vegetans of the right parieto-occipital scalp in patient with DOCK8
deficiency.

Figure 2. Left periorbital HSV vegetans in patient with DOCK8 deficiency.

